Results 111 to 120 of about 9,611,577 (169)

Inactivation of interleukin-15 reduces spontaneous atherosclerosis in <i>apolipoprotein E</i>-deficient mice. [PDF]

Front Physiol
Dadoo O, Sokeechand BSH, Lee A, Fuller MT, Wang YCD, MacDonald ME, Batenburg NL, Igdoura SA, Richards CD, Ashkar AA, Trigatti BL.   +10 more
europepmc   +1 more source

Serological and molecular assessment of severe fever with thrombocytopenia syndrome virus infection in wild boars from two adjacent endemic prefectures in Japan. [PDF]

J Vet Med Sci
Mekata H, Kimitsuki K, Yamamoto M, Umeki K, Yahiro T, Miyahara R, Nishizono A, Okabayashi T.   +7 more
europepmc   +1 more source

An inactivated human adenovirus type 55 vaccine attenuates pulmonary pathology in a non-human primate challenge model. [PDF]

Virus Res
Lee JY, Choi JA, Jung DI, Park Y, Yang E, Kim C, Ko M, Baek SH, Hong JJ, Kwon SH, Kim WT, Song M, Seo SH.   +12 more
europepmc   +1 more source

Heritable transgenic schistosomes as a living platform for SARS-CoV-2 neutralizing antibody secretion. [PDF]

Nat Commun
Ittiprasert W, Smout MJ, Mann VH, Moyle M, Kinahan SM, Ackerman DN, Rivera DN, Santarpia JL, Carnes EC, Mentink-Kane MM, Costa MR, Hokke CH, Roestenberg M, Bottazzi ME, Bracken BK, Rosa BA, Djuranovic S, Pickering DA, Giacomin PR, Watterson D, Modhiran N, Moescheid MF, Grevelding CG, Mitreva M, Loukas A, Brindley PJ.   +25 more
europepmc   +1 more source

New Insights Into an Old Vaccine: Potency and Breadth of Neutralizing Antibodies Elicited by Yellow Fever Vaccine 17D Are Boosted by Heterologous Orthoflavivirus Infection. [PDF]

J Infect Dis
Coulter FJ, Micheletti CA, Estrada AE, Luo S, Osman SR, Nix CD, Hu SY, Sampouw SM, Kareko BW, Naleway AL, Messer WB.   +10 more
europepmc   +1 more source

An engineered anti-Oropouche virus human-murine chimeric immunoglobulin M is a viable substitute for positive human serum controls in diagnostic serology assays. [PDF]

PLoS Negl Trop Dis
Miazgowicz KL, Goodman CH, Calvert AE.
europepmc   +1 more source

Molecular cloning of a monkeypox virus clade IIb genome and construction of an attenuated mutant for basic and translational research. [PDF]

Emerg Microbes Infect
Klatt V, Meyer Zu Natrup C, Staliunaite L, Clever S, Knickmann J, Ohrnberger S, Seib J, Ostermann E, Weichel HM, Addo MM, Volz A, Brune W.   +11 more
europepmc   +1 more source

Vaccinia virus and Monkeypox virus neutralizing and antigen-binding antibodies following subcutaneous and reduced intradermal doses of an MVA vaccine. [PDF]

Vaccine
Moss B, Cotter CA, Americo JL, Ignacio MA, Bassler JE, Frey SE, Beigel JH.   +6 more
europepmc   +1 more source

Molecular basis for protection and cross-protection by human antibodies targeting the parainfluenza virus hemagglutinin-neuraminidase protein. [PDF]

J Virol
McCaffrey KD, Esfahani BG, Elbehairy MA, McCormick AL, Mousa JJ.   +4 more
europepmc   +1 more source

Development of a novel hybrid alphavirus-Nipah virus pseudovirion for rapid quantification of vaccine-induced neutralization antibodies. [PDF]

Emerg Microbes Infect
Hetrick B, Nakka SS, Yu D, Swineford S, Storm N, Griffiths A, Wu Y.   +6 more
europepmc   +1 more source